CD79A and myeloid sarcoma: By assessing the isotypic pattern and serum concentration of ETX-reacting antibodies, our study brings new findings that reveal a predominant IgM response over IgG and IgA antibody responses both in MS patients and controls and, moreover, significantly higher levels of IgM reacting to ETX in MS patients compared to controls.